Table 2

Changes in cardiovascular risk factors in patients with PsA and matched controls (values obtained from the mixed linear model)

PsA (n=151)Matched controls (n=755)Difference in mean change between groups (95% CI)P crude
value
HUNT2
(1995–1997)
HUNT3
(2006–2008)
Mean changeHUNT2
(1995–1997)
HUNT3
(2006–2008)
Mean change
Weight, kg80.4 (78.2 to 82.7)82.5 (80.2  to 84.7)2.06 (0.90  to 3.22)75.9 (74.5  to 77.3)79.8 (78.4  to 81.2)3.88 (3.36  to 4.40)−1.82 (−3.98 to −0.55)<0.01NA
BMI, kg/m2 27.3 (26.6 to 27.9)28.2 (27.6  to 28.9)0.97 (0.57  to 1.37)25.9 (25.6  to 26.3)27.5 (25.2  to 27.8)1.53 (1.35 to 1.70)−0.65 (−1.00 to −0.12)0.01NA
Triglycerides1.87 (1.70 to 2.04)1.80 (1.62  to 1.97)−0.07 (−0.25 to 0.11)1.69 (1.60  to 1.77)1.69 (1.60  to 1.77)0.00 (−0.08  to 0.08)−0.07 (−0.27 to 0.12)0.460.99*
Total cholesterol5.85 (5.68 to 6.03)5.57 (5.39  to 5.74)−0.29 (−0.48 to −0.10)5.78 (5.69  to 5.90)5.71 (5.62  to 5.81)−0.06 (−0.15 to 0.02)−0.22 (−0.43 to −0.02)0.040.08*
LDL cholesterol4.82 (4.66 to 4.10)3.44 (3.28  to 3.60)−1.39 (−1.56 to −1.21)4.81 (4.73 to 4.89)3.60 (3.52  to 3.70)−1.2 (−1.28 to −1.13)−0.18 (−0.38 to 0.01)0.060.11*
HDL cholesterol1.32 (1.26 to 1.37)1.32 (1.26  to 1.38)0.00 (−0.04  to 0.05)1.39 (1.36 to 1.42)1.36 (1.33  to 1.39)−0.03 (−0.05 to −0.02)0.04 (−0.01 to 0.09)0.130.45*
Systolic blood pressure132.8 (129.9  to 135.6)132.1 (129.1 to 135.1)−0.65 (−3.63  to 2.32)131.5 (129.9 to 133.1)131.6 (129.9 to 133.2)0.02 (−1.31 to 1.35)−0.67 (−3.93 to 2.59)0.690.98†
Diastolic blood pressure79.9 (78.2  to 81.6)75.5 (73.7  to 77.3)−4.42 (−9.22 to −2.62)79.1 (78.1  to 79.9)75.1 (74. 1  to 76.1)−3.96 (−4.76 to −3.15)−0.46 (−2.43 to 1.52)0.650.90†
  • Values are mean (95% CI). Difference in mean change between groups with 95% CI is calculated with mixed models as mean of the patients with PsA minus mean of the matched controls.

  • *Adjusted for BMI and smoke at baseline.

  • †Adjusted for BMI, smoke and use of antihypertensive medication at baseline.

  • BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NA, not applicable; PsA, psoriatic arthritis.